Correlation Engine 2.0
Clear Search sequence regions
Bookmark Forward

QuickView for mecamylamine (compound)


PubChem
Name: Mecamylamine
PubChem Compound ID: 10932563
Description: A nicotinic antagonist that is well absorbed from the gastrointestinal tract and crosses the blood-brain barrier. Mecamylamine has been used as a ganglionic blocker in treating hypertension, but, like most ganglionic blockers, is more often used now as a research tool.
Molecular formula: C11H21N
Molecular weight: 167.291 g/mol
DrugBank
Identification
Name: Mecamylamine
Name (isomeric): DB00657
Drug Type: small molecule
Description: A nicotinic antagonist that is well absorbed from the gastrointestinal tract and crosses the blood-brain barrier. Mecamylamine has been used as a ganglionic blocker in treating hypertension, but, like most ganglionic blockers, is more often used now as a research tool.
Synonyms:
2-Methylaminoisocamphane; 3-Methylaminoisocamphane hydrochloride; 3-Methylaminoisocamphane; Mecamilamina; 2-Methylamino-2,3,3-trimethylnorbornane; Mecamylamine Hydrochloride
Brand: Inversine hydrochloride, Revertina, Mekamine, Mecamine hydrochloride, Versamine, Mecamine, Mevasin hydrochloride, Mekamin hydrochloride, Inversine, Mevasine
Category: Ganglionic Blockers, Nicotinic Antagonists, Antihypertensive Agents
CAS number: 60-40-2
Pharmacology
Indication: For the treatment of moderately severe to severe essential hypertension and in uncomplicated cases of malignant hypertension
Pharmacology:
Mecamylamine is a potent, oral antihypertensive agent and ganglion blocker, and is a secondary amine. Mecamylamine is indicated for the management of moderately severe to severe essential hypertension and in uncomplicated cases of malignant hypertension. Mecamylamine reduces blood pressure in both normotensive and hypertensive individuals. A small ...
show more »
Mechanism of Action: Mecamylamine is a ganglionic blocker which prevents stimulation of postsynaptic receptors by acetylcholine released from presynaptic nerve endings. The hypotensive effect of Mecamylamine is attributed to reduction in sympathetic tone, vasodilation, and reduced cardiac output, and is primarily postural.
Absorption: Mecamylamine is almost completely absorbed from the gastrointestinal tract
Protein binding: 40%
Route of elimination: Mecamylamine is excreted slowly in the urine in the unchanged form. The rate of its renal elimination is influenced markedly by urinary pH. Alkalinization of the urine reduces, and acidification promotes, renal excretion of mecamylamine. Mecamylamine crosses the blood-brain and placental barriers.
Affected organisms: Humans and other mammals

Targets